Singapore Association of Pharmaceutical Industries

What Singapore Association of Pharmaceutical Industries does

Singapore Association of Pharmaceutical Industries (SAPI) is a non-profit industry association founded on 26 May 1966 (originally as the Pharmaceutical Trade Association, renamed on 19 December 1975) that represents research-based biopharmaceutical multinational companies operating in Singapore. Its members are Ordinary Members (pharmaceutical companies directly marketing products in Singapore, typically research-based multinationals with novel/innovative products) and Associate Members (entities engaged in promotion, advertising, market research, or publication related to medicinal products), with the membership totaling 30+ Ordinary Members and 8 Associate Members. SAPI does not develop proprietary technology; its "products" are governance frameworks, standards, and policy outputs — specifically the SAPI Code of Conduct (a self-regulatory framework for pharmaceutical marketing), a portfolio of guidelines (patient interactions, patient support programs, sponsorship, virtual engagement, competition), and position papers on topics such as cancer burden and IP innovation.

SAPI's operating model is member-driven and community-led. A 12-person Board of Directors (1 President, 2 Vice-Presidents, 9 Directors) is composed of senior executives from member companies (e.g., Novartis, Roche, AstraZeneca, BMS, J&J, Sanofi, MSD, DKSH) and serves two-year terms. Day-to-day operations are run by a 4-person secretariat led by an Executive Director. The association organizes six standing committees (Finance & Development, Ethics & Business Integrity, Public Policy, Regulatory Affairs, R&D, Supply Chain) and runs events including AGMs, board meetings, and workshops. Its revenue model is subscription-based, generated through annual membership fees that are not publicly disclosed; there are no published pricing tiers. The association directs prospective members to contact [email protected] for fee details.

SAPI's strategic value lies in its role as the recognized industry voice: it engages in collaborative dialogue with the Health Sciences Authority (HSA), Ministry of Health (MOH), Agency for Care Effectiveness (ACE), and international bodies including IFPMA, APAC, and PhRMA. It was recognized by the Prime Minister of Singapore for its contributions to health and the economy. Distribution is single-country (Singapore) and entirely domestic; the association publishes content via its website and direct member communications, with no commercial product distribution.

Name

Singapore Association of Pharmaceutical Industries

Legal name

Singapore Association of Pharmaceutical Industries

Website

https://sapi.org.sg

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

1–10 employees

Short description

Singapore Association of Pharmaceutical Industries (SAPI) is a non-profit trade association founded in 1966 that represents research-based biopharmaceutical multinational companies operating in Singapore. It provides industry advocacy, self-regulatory guidelines, and a unified voice in dialogue with government health regulators.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Technical Committees, Working Groups & Expert Panels (BPADANAB)

Keywords

• Pharmaceutical industry association
• Biopharmaceutical industry advocacy
• Pharmaceutical code of conduct
• Industry self-regulation
• Healthcare policy advocacy

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: SAPI generates revenue through annual membership fees from Ordinary Members (pharmaceutical companies marketing products in Singapore) and Associate Members (entities engaged in promotion, advertising, market research, or publication of medicinal products).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

SAPI is an industry association that represents research-based biopharmaceutical companies operating in Singapore. It delivers its value through a self-regulatory SAPI Code of Conduct, a set of industry guidelines for interactions with patients and sponsorship of third-party events, policy position papers, and a tiered membership program (Ordinary Members and Associate Members). The association facilitates industry collaboration through six specialized committees (Finance & Development, Ethics & Business Integrity, Public Policy, Regulatory Affairs, R&D, Supply Chain), AGMs, and Board meetings, while engaging in advocacy and dialogue with government bodies such as the Ministry of Health, Health Sciences Authority, and Agency for Care Effectiveness.

Product overview

Singapore Association of Pharmaceutical Industries (SAPI) is a pharmaceutical industry association, not a product company. It operates as a unified membership-based organization offering governance frameworks, ethical guidelines, and industry standards. The core offerings include the SAPI Code of Conduct (self-regulatory framework for pharmaceutical marketing), SAPI Guidelines (various standards for patient interactions, sponsorship, and competitions), Position Papers (policy advocacy documents), and the SAPI Constitution. Additionally, SAPI facilitates member collaboration through regular events including Board Meetings, AGMs, and six specialized committees covering Finance, Ethics, Public Policy, Regulatory Affairs, R&D, and Supply Chain. The association's membership structure includes 30+ Ordinary Members (research-based biopharmaceutical multinational companies) and 8 Associate Members (service providers in the pharmaceutical ecosystem).

Differentiator

Problem solved

Functional benefit

Products and services

• SAPI Code of Conduct

Quantifiable outcome

• SAPI recognized by the Prime Minister of Singapore for contribution to health and economy of Singapore

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered minor, core and moderate.

• Academy of Medicine SingaporeminorOthersListed as a local useful link on SAPI website, indicating collaboration or working relationship in the healthcare ecosystem.
• Agency for Care Effectiveness (ACE)coreStrategic or Co-development PartnerSingapore's health technology assessment agency. SAPI engages in consultations with ACE as documented in media releases and consultation documents.
• Agency for Integrated CareminorOthersListed as a local useful link, indicating working relationship in Singapore's healthcare ecosystem.
• Centre of Regulatory Excellence (CoRE)coreStrategic or Co-development PartnerJoint initiative between Duke-NUS and industry stakeholders for regulatory excellence in healthcare.
• Health Sciences Authority (HSA)coreStrategic or Co-development PartnerSingapore's regulatory body for health products. SAPI Board meets with HSA and LSIG (Light Sheet Impairment Group) as documented in events calendar.
• Ministry of Health SingaporecoreStrategic or Co-development PartnerSAPI promotes understanding of innovative medicines through effective dialogues with the Ministry of Health.
• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)coreStrategic or Co-development PartnerGlobal industry association representing research-based pharmaceutical companies. SAPI listed as a useful international link.
• Asia Partnership Conference of Pharmaceutical Associations (APAC)moderateStrategic or Co-development PartnerRegional partnership of pharmaceutical associations across Asia Pacific.
• Pharmaceutical Research and Manufacturers of America (PhRMA)minorOthersListed as an international useful link for industry reference.
• Consumer Healthcare Products Association (CHPA)minorOthersListed as an international useful link for industry reference.
• Singapore Business FederationminorOthersListed as a local useful link indicating SAPI's connection to Singapore's business community.
• Singapore Manufacturing FederationminorOthersListed as a local useful link indicating connection to Singapore's manufacturing sector.
• Singapore CustomsminorOthersListed as a local useful link relevant to pharmaceutical import/export.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Japan Pharmaceutical Manufacturers Association (JPMA): National pharma industry association for Japan. Closely comparable in structure and mission to SAPI (representing R&D-based pharma companies, operating a promotion Code of Conduct), but operating in a much larger domestic market.
• Association of the British Pharmaceutical Industry (ABPI): UK pharma industry association running the well-known ABPI Code of Practice. Directly comparable to SAPI as a national research-based pharma trade association with a detailed self-regulatory code and government engagement.
• Medicines Australia: Australian pharma industry association. Comparable in mission and operating model to SAPI; useful as an Asia-Pacific peer given geographic and regulatory proximity to Singapore.
• Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA): Korean national pharma manufacturers association. Comparable peer to SAPI as a research-based pharma industry body in a neighboring Asia-Pacific market with similar self-regulatory and government-engagement functions.
• Pharmaceutical Association of Malaysia (PhAMA): Malaysian pharma industry association. Most direct geographic peer to SAPI as a Southeast Asian national body representing research-based pharma with a Code of Conduct and government engagement mandate.

Broad incumbents

• European Federation of Pharmaceutical Industries and Associations (EFPIA): European pharma industry association. Comparable in mission (research-based pharma representation, Code on promotional practices) but operating at EU-level scale; useful benchmark for SAPI's broader advocacy ambitions.
• Pharmaceutical Research and Manufacturers of America (PhRMA): The leading US pharmaceutical industry association. Comparable to SAPI in core function (representing research-based pharma and operating a Code/ethics framework) but operating at far greater scale in a different geography; relevant as a benchmark for SAPI's Code-of-Conduct and advocacy model.
• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): Global pharma industry body already listed as a strategic partner of SAPI. Directly comparable in mission (research-based pharma representation, Code of Practice) and provides the global umbrella under which SAPI operates.

Emerging players

• Asia Partnership Conference of Pharmaceutical Associations (APAC): Regional partnership of pharmaceutical associations across Asia Pacific, of which SAPI is a participant. Comparable as a peer-level association structure focused on harmonization of regulatory and access standards.

Others

• Singapore Medical Association (SMA): Singapore's national medical professional association. Not a direct competitor but a closely adjacent local counterpart that SAPI engages with through stakeholder dialogues on healthcare policy and innovative medicines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sapisingapore

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Singapore Association of Pharmaceutical Industries